EU regulator reviews AstraZeneca shot and blood clot links
LONDON (AP) — The world awaited the results Thursday of an initial European investigation into whether AstraZeneca's COVID-19 vaccine is linked to blood clots reported in a small number of people who received the shot.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
